04/03/2026
Part 2: OA in YOUNG dogs...
When my friend received the radiology report confirming hip laxity and early arthritic change, she spiraled a little. And I donāt blame her. Thereās something confronting about seeing the words ādegenerative joint diseaseā attached to a dog who still feels like a baby.
Arthritis carries weight. It sounds permanent. Progressive. Like a door quietly closing.
Because weāre friends, she asked me what so many clients ask in that moment:
āIf this was your dogā¦ what would you do?ā
And I remember sitting with that question for a bit. Not because I didnāt have ideas - but because arthritis management isnāt a single decision. Itās not one supplement, one injection, one exercise plan. Itās a long game, just as progressive as the condition it treats.
The interesting thing was that she already had so many protective pieces in place. He was lean. He swam regularly. His lifestyle didnāt revolve around repetitive high-impact work. We could easily adjust his exercise to favour strength and control over intensity. We layered in specific hip strengthening within his training sessions. We looked at flooring, stairs, environmental stressors. His nutrition was already thoughtful.
What this experience reinforced for me is something we often discuss clinically but donāt always communicate clearly to owners: osteoarthritis evolves, and our management needs to evolve with it.
Early-stage disease is not the same as moderate or advanced disease. The joint environment changes. The inflammatory drivers shift. Compensation patterns build over time. What a one-year-old dog with early laxity needs is very different from what that same dog might need at seven.
That staged approach isnāt just theoretical. Itās supported by growing consensus in the literature. The treatment framework outlined in the COAST (Canine OsteoArthritis Staging Tool) guidelines, for example, emphasizes matching intervention intensity to disease stage - starting with foundational weight, exercise, and environmental strategies, and progressively layering pharmacologic and advanced therapies as clinical signs evolve. It moves us away from both under-treating early disease and overloading mild cases with unnecessary interventions.
When we think in stages, the diagnosis becomes less overwhelming. It shifts from āHow do I fix this?ā to āWhat does this dog need right now?ā
And maybe thatās the more empowering question.
If youād like a structured breakdown of how treatment recommendations shift through the stages of progression, weāve unpacked the guidelines in detail in our blog. Link in the comments
Iād love to hear - when youāre faced with early OA in a young dog, how do you decide what to implement immediately, and what to thoughtfully reserve for later?
